About Institute for Skin Advancement
Clinical Trials at Institute for Skin Advancement
During the past decade, Institute for Skin Advancement conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 11 clinical trials were completed, i.e. on
average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 11 clinical trials were completed. i.e. 275%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Institute for Skin Advancement" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Amgen" with 2 trials
sponsored, "Dermira, Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Celgene"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Skin Advancement"
#1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Institute for Skin Advancement
According to Clinical.Site data, the most researched conditions in "Institute for Skin Advancement" are
"Atopic Dermatitis" (4 trials), "Psoriasis" (4 trials), "Acne Vulgaris" (3 trials), "Dermatitis, Atopic" (2 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Institute for Skin Advancement" in a lesser frequency.
Clinical Trials Intervention Types at Institute for Skin Advancement
Most popular intervention types in "Institute for Skin Advancement" are "Drug" (13 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Apremilast" (3 trials), "Lebrikizumab" (2 trials), "Olumacostat Glasaretil Gel, 5.0%" (2 trials) and "BMS-986165" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institute for Skin Advancement
The vast majority of trials in "Institute for Skin Advancement" are
15 trials for "All" genders.
Clinical Trials Status at Institute for Skin Advancement
Currently, there are NaN active trials in "Institute for Skin Advancement".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Institute for Skin Advancement,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institute for Skin Advancement, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".